CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 3426-3433

  Lopalco, Lucia ^a   Barassi, Claudia ^a   Pastori, Claudia ^a   Longhi, Renato ^b   Burastero, Samuele E ^a   Tambussi, Giuseppe ^a   Mazzotta, Francesco ^c   Lazzarin, Adriano ^a   Clerici, Mario ^d   Siccardi, Antonio G ^e  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b CNR   (Italy)

^c SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e Dipto Biol/Genet Sci Mediche   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CONFORMATIONAL TRANSITION; DRUG EFFECT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; PRIORITY JOURNAL; SEROCONVERSION; STRAIN DIFFERENCE; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

EID: 0034653980     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.3426     Document Type: Article

References (45)

1. Lopalco, L., C. Pastori, A. Cosma, S. E. Burastero, B. Capiluppi, E. Boeri, A. Beretta, A. Lazzarin, and A. G. Siccardi. 2000. Anti cell antibodies in exposed seronegative individuals with HIV-1 neutralizing activity. AIDS Res. Hum. Retrovir. 16:109.
2. Beretta, A. L. Furci, S. Burastero, A. Cosma, M. E. Dinelli, L. Lopalco, C. DeSantis, G. Tambussi, E. Carrow, S. Sabbatani, et al. 1996. HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection. Immunol. Lett. 51:39.
3. Burastero, S. E., D. Gaffi, L. Lopalco, G. Tambussi, B. Borgonovo, C. DeSantis, C. Abecasis, P. Robbioni, A. Gasparri, A. Lazzarin, et al. 1996. Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals. AIDS Res. Hum. Retrovir. 12:273.
4. Mazzoli, S., D. Trabattoni, S. Lo Caputo, S. Piconi, C. Ble, F. Meacci, S. Ruzzante, A. Salvi, F. Semplici, R. Longhi, et al. 1997. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat. Med. 3:1250.
5. Mazzoli, S., L. Lopalco, A. Salvi, D. Trabattoni, S. Lo Caputo, F. Semplici, M. Biasin, C. Ble, A. Cosma, C. Pastori, et al. 1999. HIV-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive individuals. J. Infect. Dis. 180:1171.
6. Rowland-Jones, S. L., and A. McMichael. 1995. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr. Opin. Immunol. 7:448.
7. Shearer, G. M., and M. Clerici. 1996. Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today 17:21.
8. + cell noncytotoxic anti-HIV response. Proc. Natl. Acad. Sci. USA 96:1030.
9. Clerici, M., J. V. Giorgi, C. C. Chou, V. K. Gudeman, J. A. Zack, P. Gupta, H.-N. Ho, P. G. Nishanian, J. A. Berzofsky, and G. M. Shearer. 1992. Cell-mediated immune response to human immunodeficiency virus (HIV) type-I in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 165:1012.
10. Clerici, M., J. M. Levin, H. A. Kessler, A. Harris, J. A. Berzofsky, A. L. Landay and G. M. Shearer. 1994. HIV-specific T helper activity in seronegative health care workers exposed to contaminated blood. J. Am. Med. Assoc. 271:42.
11. Pinto, L. A., J. Sullivan, J. A. Berzofsky, M. Clerici, H. A. Kessler, A. L. Landay, and G. M. Shearer. 1995. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest. 96:867.
12. + T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele. J. Exp. Med. 186:455.
13. Cheynier, R. P., P. Langlade-Demoyen, M. R. Marescot, and F. Plata. 1992. Cytocoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1 infected mothers. Eur. J. Immunol. 22:2211.
14. Langlade-Demoyen, P., N. Ngo-Giang-Huong, F. Ferchal, and E. Oksenhendler. 1994. HIV-nef specific cytotoxic T lymphocytes in non-infected heterosexual contact of HIV-infected patients. J. Clin. Invest. 93:1293.
15. Rowland-Jones, S. L. 1994. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59.
16. Langlois, A. J., K. J. Weinhold, T. J. Mattheus, M. L. Greenberg, and D. P. Bolognesi. 1992. The ability of certain SIV vaccines to provoke reactions against normal cells. Science 255:292.
17. Stott, E. J. 1991. Anti-cell antibody in macaques. Nature 353: 393.
18. Chan, W. L, A. Rodgers, C. Grief, N. Almond, S. Ellis, B. Flanagan, P. Silvera, J. Bootman, J. Stott, and K. Kent. 1995 Immunization with class I human histocompatibility leukocyte antigen can protect macaques against challenge infection with SIVmac-32H. AIDS 9:223.
19. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:1.
20. + lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nat. Med. 2:412.
21. Quillent, C., E. Oberlin, J. Braun, D. Roussel, G. Gonzalez-Canali, P. Metais, L. Montagnier, J. L. Virelizier, F. Arenzana-Seisdedos, and A. Beretta. 1998. HIV-1 resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 351:14.
22. Kostrikis, L. 1998. The 641 allele of CCR2 delays HIV-1 disease progression and is associated with a mutation within the CCR5 regulatory region. Nat. Med. 4:350.
23. Berger, E. A., R. W. Doms, E. M. Fenyo, B. T. Korber, D. R. Littman, J. P. Moore, Q. J. Sattentau, H. Schuitemaker, J. Sodroski, and R. A. Weiss. 1998. A new classification for HIV-1. Nature 391:240.
24. Blaak, H., A. B. Van't Wout, M. Brouwer, M. Cornelissen, N. A. Kootstra, N. Albrecht-van Lent, R. P. Keet, J. Goudsmit, R A. Coutinho, and H. Schuitemaker. 1998. Infectious cellular load in human immmunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples. J. Virol. 72:218.
25. Stewart, G. 1998. Chemokine genes beating the odds. Nat. Med. 4:275.
26. Simmons, G., R. R. Clapham, L. Picard, R. E. Offord, M. M. Rosenkilde, T. W. Schwartz, R. Buser, T. N. C. Wells, and A. E. Proudfoot. 1997. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276:276.
27. Moore, J. P. 1997. Coreceptors: implications for HIV pathogenesis and therapy. Science 276:51.
28. Cohen, J. 1997. Exploiting the HIV-chemokine nexus. Science 275:1261.
29. Trkola, A., T. Ketas, V. N. Kewalramani, F. Endorf, J. M. Binley, H. Katinger, J. Robinson, D. R. Littman and J. P. Moore. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR5. Nature 384:184.
30. Grassi, F., R. Meneveri, M. Gullberg, L. Lopalco, G.B. Rossi, P. Lanza, C. De Santis, G. Brattsand, S. Butto, E. Ginelli, and A.G. Siccardi. 1991. Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope home by class I major histocompatibility complex heavy chains. J. Exp. Med. 174:53
31. Wu, L., W. A. Paxton, N. Kassam, N. Ruffing, J. B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, R. A. Koup, and C. R. Mackay. 1997. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1. in vitro. J. Exp. Med. 185:1681.
32. Moore, J. P., J. A. McKealing, Y. Huang, A. Ashkenazi, and D. D.Ho. 1992. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycopreotein gp120 retention from sCD4-sensitive isolates. J. Virol. 66:235.
33. Zolla Pazner, S., and S. Sharpe. 1995. A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates. AIDS Res. Hum. Retovir. 11:1449.
34. Fields, G. B., and R. L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Prot. Res. 35:161.
35. Kings, D. S., C. G. Fields, and G. B. Fields. 1990. A cleveage method which minimizes side chain reactions following Fmoc solid phase peptide synthesis. Int. J. Pept. Prot. Res. 36:255.
36. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CCCKR5: a RANTES, MIP-1α, MIP-1β, receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955.
37. D'Souza, M. P., and V. Harden. 1996. Chemokines and HIV-1 second receptors. Nat. Med. 2:1293.
38. + T cells. Science 270:1811.
39. Trkola, A., W. A. Paxton, S. P. Monard, J. A. Hoxie, M. A. Siani, D. A. Thompson, L. Wu, C. R. Mackay, R. Horuk, and J. P. Moore. 1998. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokmes. J. Virol. 72:396.
40. Wu, L., G. LaRosa, N. Kassam, C. J. Gordon, H. Heath, N. Ruffing, H. Chen, J. Humblias, M. Samson, M, Parmentier, J. P. Moore, and C. R. Mackay. 1997. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186:1373.
41. Chackerian, B., D. R. Lowy, and J. T. Schiller. 1999. Induction of autoantibodies to mouse CCR5 with recombinant papilloma virus. Proc. Nat. Acad. Sci. USA 96:2373.
42. Bachmann, M. F., and R. M. Zinkernagel. 1997. Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15:235.
43. Lehner, T., Y. Wang, C. Doyle, L. Tao, L. A. Bergmeier, E. Mitchell, W. M. J. Bogers, J. Heeney, and C. G. Kelly. 1999. Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques. Eur. J. Immunol. 28:877.
44. Ditzel, H. J., M. M. Rosenkilde, P. Garred, M. Wang, K. Koefoed, C. Pedersen, D. R. Burton, and T. W. Schwartz. 1998. The CCR5 receptor acts as an alloantigen in CCR5Δ32 homozygous individuals: identification of chemokine- and HIV-1-blocking human antibodies. Proc. Nat. Acad. Sci. USA 95:5241
45. Zuber, B., M. Levi, M. Karlsson, B. M. Sioberg, M. Brytting, and B. Wahren. 1998. Immune reaction against the HIV-1 coreceptor CCR5. Third European Conference on AIDS Research, Munich, Germany, p. 6.S1. (Abstr.).